CD4+ T cells in sarcoidosis: Targets and tools

Expert Review of Clinical Immunology

Volumn 2, Issue 6, 2006, Pages 877-886

  Grunewald, Johan ^a   Eklund, Anders ^a   Wahlström, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bronchoalveolar lavarge; CD4 T cell; Natural killer T cell; Regulatory T cell; Sarcoidosis; Specific antigens; T helper cell; T lymphocytes

Indexed keywords

EID: 84872526229     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2.6.877     Document Type: Review

References (75)

1. Janeway C, Travers P, Walport M, Shlomchik M. Immunobiology. The Immune System in Health and Disease, (5th Edition). Garland Publishing, NY, USA (2001).
2. Romagnani S. Biology of human TH1 and TH2 cells. J. Clin. Immunol. 15(3), 121-129 (1995).
3. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609), 1057-1061 (2003). (Pubitemid 36222930)
4. + regulatory T cells. Nat. Immunol. 4(4), 330-336 (2003). (Pubitemid 36432314)
5. Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 3(2), 171-174 (1995).
6. Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27(1), 68-73 (2001). (Pubitemid 32044521)
7. Wildin RS, Ramsdell F, Peake J et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27(1), 18-20 (2001). (Pubitemid 32044512)
8. van Oosterhout Aj, Bloksma N. Regulatory T-lymphocytes in asthma. Eur. Respir. J. 26(5), 918-932 (2005). (Pubitemid 41632052)
9. Zhou D, Mattner J, Cantu C 3rd et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306(5702), 1786-1789 (2004). (Pubitemid 39601398)
10. Kinjo Y, Wu D, Kim G et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434(7032), 520-525 (2005). (Pubitemid 40477061)
11. Naidenko OV, Maher JK, Ernst WA, Sakai T, Modlin RL, Kronenberg M. Binding and antigen presentation of ceramid-containing glycolipids by soluble mouse and human CD1d molecules. J. Exp. Med. 190(8), 1069-1080 (1999).
12. Sharif S, Arreaza GA, Zucker P et al. Activation of natural killer T cells by α-galactosykeramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 7(9), 1057-1062 (2001). (Pubitemid 32937388)
13. Hong S, Wilson MT, Serizawa I et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7(9), 1052-1056(2001). (Pubitemid 32937387)
14. Wilson SB, Kent SC, Patton KT et al. Extreme Th1 bias of invariant V α24J αQ T cells in type 1 diabetes. Nature 391 (6663), 177-181 (1998). (Pubitemid 28092476)
15. Pabst R, Tschernig T. Lymphocyte dynamics: caution in interpreting BAL numbers. Thorax 52(12), 1078-1080 (1997). (Pubitemid 27515789)
16. Pabst R, Binns RM. Lymphocytes migrate from the bronchoalveolar space to regional bronchial lymph nodes. Am. J. Respir. Crit. Care Med. 151(2 Pt 1), 495-499 (1995).
17. Krug N, Tschernig T, Holgate S, Pabst R. How do lymphocytes get into the asthmatic airways? Lymphocyte traffic into and within the lung in asthma. Clin. Exp. Allergy 28(1), 10-18 (1998). (Pubitemid 28053922)
18. Toews G. Cytokines and the lung. Eur. Resp. J. 18(Suppl.), 3-17 (2001).
19. Lern VM, Lipscomb MF, Weissler JC et al. Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation. J. Immunol. 135(3), 1766-1771 (1985). (Pubitemid 16245360)
20. Nicod LP, Isler P. Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L. Am. J. Respir. Cell. Mol. Biol. 17(1), 91-96 (1997). (Pubitemid 127500825)
21. Grunewald J, Eklund A, Wigzell H, Van Meijgaarden KE, Ottenhoff TH. Bronchoalveolar lavage cells from sarcoidosis patients and healthy controls can efficiendy present antigens. J. Intern. Med 245(4), 353-357 (1999). (Pubitemid 29202211)
22. Chelen CJ, Fang Y, Freeman GJ et al. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J. Clin. Invest. 95(3), 1415-1421 (1995).
23. Newman LS, Rose CS, Maier LA. Sarcoidosis N. Engl J. Med 336(17), 1224-1234 (1997).
24. Muller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur. Respir. J. 12(3), 716-738(1998). (Pubitemid 28420156)
25. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N. Engl J. Med 305(8), 429-434 (1981). (Pubitemid 11047044)
26. Pinkston V, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N. Engl. J. Med 308(14), 793-800(1983). (Pubitemid 13114673)
27. + T cell subset. J. Clin. Invest. 77(6), 1962-1970(1986). (Pubitemid 16062653)
28. Muller-Quernheim J, Saltini C, Sondermeyer P, Crystal RG. Compartmentalized activation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis. J. Immunol. 137(11), 3475-3483 (1986). (Pubitemid 17193303)
29. Robinson BW, McLemore TL, Crystal RG. γ interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J. Clin. Invest. 75(5), 1488-1495 (1985). (Pubitemid 15041440)
30. Stridh H, Planck A, Gigliotti D, Eklund A, Grunewald J. Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis. Thorax 57(10), 897-901 (2002). (Pubitemid 35178616)
31. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am. J. Respir. Crit. Care Med. 160(2), 736-755 (1999).
32. + lung and blood T cells in sarcoidosis. Am. J. Respir. Crit. Care Med. 163(1), 115-121 (2001). (Pubitemid 32097972)
33. Moller DR, Forman JD, Liu MC et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J. Immunol. 156(12), 4952-4960(1996). (Pubitemid 26174485)
34. Shigehara K, Shijubo N, Ohmichi M et al. Enhanced mRNA expression of Th1 cytokines and IL-12 in active pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 17(2), 151-157(2000). (Pubitemid 30411831)
35. Shigehara K, Shijubo N, Ohmichi M et al. IL-12 and IL-18 are increased and stimulate IFN-γ production in sarcoid lungs. J. Immunol. 166(1), 642-649 (2001). (Pubitemid 32038488)
36. Agostini C, Trentin L, Facco M et al. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J. Immunol. 157(2), 910-918 (1996). (Pubitemid 26231399)
37. Larousserie F, Pflanz S, Coulomb-L'Hermine A, Brousse N, Kastelein R, Devergne O. Expression of IL-27 in human Th1-associated granulomatous diseases. J. Pathol. 202(2), 164-171 (2004). (Pubitemid 38208653)
38. Moller DR. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 16(1), 24-31 (1999). (Pubitemid 29164268)
39. Lukacs NW, Hogaboam C, Chensue SW, Blease K, Kunkel SL. Type 1/type 2 cytokine paradigm and the progression of pulmonary fibrosis. Chest 120(Suppl. 1), S5-S8 (2001).
40. Gudmundsson G, Hunninghake GW. Interferon-γ is necessary for the expression of hypersensitivity pneumonitis. J. Clin. Invest. 99(10), 2386-2390 (1997). (Pubitemid 27227715)
41. + lymphocyte dependence. Chest 124(3), 929-935 (2003). (Pubitemid 37123311)
42. + effector T cells develop via a lineage distinct from the T helper type I and 2 lineages. Nat. Immunol. 6(11), 1123-1132 (2005). (Pubitemid 41541790)
43. Gibejova A, Mrazek F, Subrtova D et al. Expression of macrophage inflammatory protein-3 β/CCL19 in pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 167(12), 1695-1703 (2003). (Pubitemid 36760685)
44. Agostini C, Adami F, Semenzato G. New pathogenetic insights into the sarcoid granuloma. Curr. Opin. Rheumatol. 12(1), 71-76 (2000). (Pubitemid 30036691)
45. Katchar K, Eklund A, Grunewald J. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J. Intern. Med. 254(6), 564-571 (2003). (Pubitemid 37521853)
46. Semenzato G. Immunology of sarcoidosis european Respiratory Monograph. Sarcoidosis. Drent S, Costabel U (Eds). Vol. 10 European Respiratory Society Journals Ltd, 49-63 (2006).
47. Wahlstrom J, Berlin M, Skold CM, Wigzell H, Eklund A, Grunewald J. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid trom patients with pulmonary sarcoidosis. Thorax 54(4), 339-346 (1999). (Pubitemid 29150163)
48. + lung T-cell expansions in pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 163(7), 1540-1545 (2001). (Pubitemid 32578752)
49. Hol BE, Hintzen RQ, Van Lier RA, Alberts C, Out TA, Jansen HM. Soluble and cellular markers of T cell activation in Patients with pulmonary sarcoidosis. Am. Rev. Respir. Dis. 148(3), 643-649 (1993). (Pubitemid 23263773)
50. Moller DR, Konishi K, Kirby M, Balbi B, Crystal RG. Bias toward use of a specific cell receptor β-chain variable region in a subgroup of individuals with sarcoidosis. J. Clin. Invest. 82(4), 1183-1191 (1988).
51. Balbi B, Moller DR, Kirby M, Holroyd KJ, Crystal RG. Increased numbers of T lymphocytes with γ δ-positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis. J. Clin. Invest. 85(5), 1353-1361 (1990). (Pubitemid 20176426)
52. + T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur. J. Immunol. 22(1), 129-135 (1992).
53. + T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc. Natl Acad. Sci. USA 91(11), 4965-4969 (1994). (Pubitemid 24177771)
54. Bellocq A, Lecossier D, Pierre-Audigier C, Tazi A, Valeyre D, Hance AJ. T cell receptor repertoire of T lymphocytes recovered from the lung and blood of patients with sarcoidosis. Am. J. Respir. Crit. Care Med. 149(3 Pt 1), 646-654 (1994). (Pubitemid 24082221)
55. Forman JD, Klein JT, Silver RF, Liu MC, Greenlee BM, Moller DR. Selective activation and accumulation of oligoclonal V β-specific T cells in active pulmonary sarcoidosis. J. Clin. Invest. 94(4), 1533-1542(1994). (Pubitemid 24309875)
56. Forrester JM, Wang Y, Ricalton N et al. TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis. J. Immunol. 153(9), 4291-4302 (1994). (Pubitemid 24322596)
57. Klein JT, Horn TD, Forman JD, Silver RF, Teirstein AS, Moller DR. Selection of oligoclonal V β-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J. Immunol. 154(3), 1450-1460 (1995).
58. Grunewald J, Eklund A, Hed J, Takahashi H, Wigzell H. Aspects on the alveolar accumulation of T cells in sarcoidosis. Sarcoidosis 9(2), 142-144 (1992).
59. + sarcoidosis patients. Mol. Med. 1(3), 287-296 (1995).
60. Planck A, Eklund A, Grunewald J. Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients. Eur. Respir. J. 21(1), 52-57 (2003). (Pubitemid 36150301)
61. Grunewald J, Berlin M, Olerup O, Eklund A. Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 161(3 Pt 1), 814-818 (2000). (Pubitemid 30171736)
62. Grunewald J, Shigematsu M, Nagai S et al. T-cell receptor V gene expression in HLA-typed Japanese patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 151(1), 151-156 (1995).
63. Grunewald J, Eklund A. Human leukocyte antigen genes may outweigh racial background when generating a specific immune response in sarcoidosis. Eur. Respir. J. 17(5), 1046-1048 (2001). (Pubitemid 32600353)
64. Grunewald I, Eklund A. Specific bronchoalveolar lavage fluid T cells associate with disease in a pair of monozygotic twins discordant for sarcoidosis. J. Intern. Med. 250(6), 535-539 (2001). (Pubitemid 34013512)
65. + T cell expansions in sarcoidosis patients with a shared HLA-DR β chain conformation. Thorax 57(4), 348-352 (2002). (Pubitemid 34298934)
66. *0101 (DR52a)-restricted epitope cross-presented by DR3: overlapping natural and artificial determinants in the human acetylcholine receptor. J. Immunol. 162(7), 4079-4087 (1999). (Pubitemid 29314791)
67. Song Z, Marzilli L, Greenlee BM et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J. Exp. Med. 201(5), 755-767 (2005). (Pubitemid 40395121)
68. +) individuals upon stimulation with Mycobacterium tuberculosis. Infect. Immun. 67(8), 3800-3809 (1999). (Pubitemid 29356995)
69. Grutters JC, Sato H, Welsh Kl, du Bois RM. The importance of sarcoidosis genotype to lung phenotype. Am. J. Respir. Cell. Mol. Biol. 29(Suppl. 3), S59-S62 (2003). (Pubitemid 37070310)
70. Ho LP, Urban BC, Thickett DR, Davies RJ, McMichael AJ. Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis. Lancet 365(9464), 1062-1072 (2005). (Pubitemid 40386784)
71. Kobayashi S, Kaneko Y, Seino K et al. Impaired IFN-γ production of V α24 NKT ceils in non-remitting sarcoidosis. Int. Immunol. 16(2), 215-222 (2004). (Pubitemid 38195651)
72. Mempel M, Flageul B, Suarez F et al. Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of V a24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor V α repertoire. Am. J. Pathol. 157(2), 509-523 (2000). (Pubitemid 30627561)
73. + natural killer T cells in bronchial asthma. AC Engl. J. Med. 354(11), 1117-1129 (2006).
74. Planck A, Katchar K, Eklund A, Gripenback S, Grunewald J. T-lymphocyte activity in HLA-DR17 positive patients with active and clinically recovered sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 20(2), 110-117(2003). (Pubitemid 36841691)
75. Miyara M, Amoura Z, Parizot C et al. The immune paradox of sarcoidosis and regulatory T cells. J. Exp. Med 203(2), 359-370 (2006). (Pubitemid 43290845)